Efectividad de anticuerpos monoclonales anti-PRGC en el tratamiento preventivo de la migraña: estudio prospectivo de 63 pacientes-Reference-Cited by-同舟云学术

Efectividad de anticuerpos monoclonales anti-PRGC en el tratamiento preventivo de la migraña: estudio prospectivo de 63 pacientes

Published:2023-04 Issue:8 Volume:160 Page:341-346
ISSN:0025-7753
Container-title:Medicina Clínica
language:es
Short-container-title:Medicina Clínica

Author:

Castrillo Ana,Mendoza Amelia,Caballero Lorena,Cerdán Débora,Rodríguez María Fernanda,Guerrero Pilar,Tabernero César,Ferrero Marta,Benito Inés,Marín Laura,Duarte Jacinto

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016;Vos;Lancet.,2017

2. MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention;Belvís;J Headache and Pain.,2021

3. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition;Cephalalgia,2018

4. Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: a retrospective claims analysis;Hepp;Cephalagia.,2017

5. OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program;Dodick;Headache.,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world effectiveness and safety of erenumab for the treatment of migraine: A systematic review and meta-analysis;European Journal of Pharmacology;2024-08

2. [Artículo traducido] Análisis del retratamiento con anticuerpos monoclonales en la migraña crónica/episódica: datos en vida real;Farmacia Hospitalaria;2024-07

3. Analysis of retreatment with monoclonal antibodies in chronic/episodic migraine: Real world data;Farmacia Hospitalaria;2024-07

4. CGRP Antagonism and Ketogenic Diet in the Treatment of Migraine;Medicina;2024-01-15

5. Clinical efficacy and safety of rimegepant in the treatment of migraine: a meta-analysis of randomized controlled trials;Frontiers in Neurology;2023-06-20